Kirkland & Ellis is advising Altaris, LLC on the deal, and TMI Associates is advising Resonac. Altaris, LLC has announced the pending acquisition of Minaris Regenerative...
Altaris’ Acquisition of Minaris Regenerative Medicine
R.R. Donnelley & Sons’ Acquisition of Digital Print and Marketing Businesses from Vericast
Latham & Watkins LLP represented RRD, Lowenstein Sandler represented Chatham Asset Management, LLC, the sole owner of RRD, Kirkland & Ellis advised Vericast Corp. on the...
TJC’s Acquisition of Majority Stake of Delrin
Kirkland & Ellis represented TJC, while Skadden represented DuPont in the transaction. DuPont announced its definitive agreement to sell an 80.1% ownership interest in the Delrin®...
Antarctica Capital’s $100 Million Acquisition of Midwest Holding
Kirkland & Ellis represents Antarctica Capital, while Fried Frank, Lamson Dugan and Primmer Piper represent Midwest Holding. Midwest Holding Inc. (NASDAQ: MDWT) and Antarctica Capital announced they...
Kindeva Drug Delivery’s Combination With Meridian Medical Technologies
Kirkland & Ellis and ArentFox Schiff advised Altaris on the deal. Latham & Watkins represented the lenders on the financing aspects. Altaris, LLC, a healthcare investment...
Investindustrial’s Acquisition Of 52% Interest In Eataly S.p.A.
Eataly was supported by Studio Legale e Tributario Fivelex, for the legal aspects of Italian law, as well as by Tarter Krinsky & Drogin LLP, Danow,...
Investindustrial’s Acquisition of Significant Portion of TreeHouse Foods’ Meal Preparation Division
Kirkland & Ellis represented Investindustrial, while Gibson Dunn represented TreeHouse in the transaction. An investment company indirectly held by Investindustrial VII L.P. (“Investindustrial”) has signed a...
Recipharm’s Acquisition of Arranta Bio
Kirkland & Ellis represented Recipharm in the transaction. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisitions...
Recipharm’s Acquisition of Vibalogics
Kirkland & Ellis advised Recipharm on the deal. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisition of...